Search Results 31-40 of 22401 for neurofibromatosis
Neurofibromatosis type 2. Neurofibromatosis type 2 is a genetic condition that often causes multiple brain tumors and spinal tumors. Von Hippel-Lindau disease.
Dr. Larson is a pediatric orthopedic surgeon at Mayo Clinic in Rochester, Minnesota. She is also a professor of orthopedic surgery specializing in scoliosis and ...
Neurofibromatosis 1. Neurofibromatosis 1 causes tumors called neurofibromas to form in the skin. The condition also can cause tumors of the optic nerve ...
Clinical research is an important element of the Neurofibromatosis Clinic at Mayo Clinic, including clinical trials that could ultimately lead to significant ...
Description. Selumetinib is used to treat neurofibromatosis type 1 (NF1) in children 2 years of age and older who have plexiform neurofibromas that cannot be ...
For neurofibromatosis type 1 (NF1):. Adults and children 2 years of age and older—Dose is based on body surface area and must be determined by your doctor ...
A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma. Print details. Share; Facebook ...
Neurofibromatosis type 1 (NF1) and neurofibromatosis type 2 (NF2) are genetic conditions that can cause acoustic neuromas and other types of skull base tissues.
The objective of this study is to collect blood samples from living patients with neurofibromatosis type 1 (NF1) for future genomic, proteomic, metabolomic, and ...
Neurofibromatosis type 1. Neurofibromatosis type I. See. Neurofibromatosis type 1. Neurofibrosarcoma. See. Malignant peripheral nerve sheath tumors. Neuroma ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift today can have 5X the impact on AI research and technology. But hurry — the match challenge ends 9/19.